Sudeep Pharma Limited will host an earnings call with analysts and investors on Wednesday, August 5, 2026, at 11:00 AM IST. The discussion will focus on the company’s operational and financial performance for the quarter ended June 30, 2026 (Q1FY27). This event provides stakeholders with an opportunity to review the latest quarterly results and address queries regarding the company’s strategic direction.

The announcement was made in compliance with Regulation 30 of the SEBI Listing Regulations, 2015. The notice was issued on July 27, 2026, by Dimple Mehta, Company Secretary & Compliance Officer of Sudeep Pharma Limited. The invitation includes access details for participants across India, the USA, the UK, Singapore, and Hong Kong.

Conference Call Details

Nuvama Wealth Management is hosting the conference call. Mr. Archit Joshi from Nuvama Wealth Management Ltd. will serve as the call leader. Participants can join via the following dial-in numbers:

Alternatively, investors may register and access the call via the link provided in the annexure of the original filing, which is also available on the company’s investor relations website.

Management Representation

The following senior executives from Sudeep Pharma Limited will represent the company during the call:

• Sujit Bhayani, Managing Director
• Shanil Bhayani, Director
• Ketan Vyas, Chief Financial Officer

What This Means for Investors

While the filing does not disclose specific financial figures such as net profit or revenue, the scheduling of this call confirms that Q1FY27 results have been finalized and are ready for dissemination. Investors should prepare questions regarding margin trends, order book status, and any operational updates relevant to the pharma sector. The absence of pre-disclosed metrics suggests that the primary source of data will be the live management commentary and any accompanying presentation materials shared during the event.

Sudeep Pharma Limited has submitted to the stock exchanges the copies of the newspaper advertisement published regarding its 37th Annual General Meeting (AGM). The notice was published in the Business Standard, Ahmedabad Edition, and Vadodara Samachar on Saturday, July 11, 2026. The submission was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The advertisement contains the Notice of the 37th AGM, along with information regarding E-Voting and Dividend Information. The company has stated that the above information is also available on its website at https://www.sudeeppharma.com/ . Dimple Mehta, the Company Secretary & Compliance Officer, signed the submission to the exchanges.

Key Dates for the 37th AGM

The notice outlines the specific schedule for the upcoming annual general meeting and the associated remote e-voting process.

The 37th AGM is scheduled to be held via Video Conferencing (VC) or other audio-visual means (OAVM). Shareholders holding shares as of the cut-off date are eligible to participate in the remote e-voting facility or vote via e-voting during the AGM.